C
HCs are and have been an important part of the United States' health care safety net for more than 40 years. 1 Indeed, society has invested in CHCs through government grants and private philanthropy; pay ments for services must be presumed to be worthwhile.
Looking to the future, potential community health partners need to know whether empirical studies demonstrate the value of CHCs to society or the communities they serve. The answer depends in part on what is meant by value.
Throughout CHCs' 40year history, health policy mak ing has often focused on whether value is being obtained from a treatment, intervention, or care system. Although the meaning of value encompasses more than economic out comes, cost effectiveness is a critical element of value in today's health policy environment. At a conceptual level, an intervention's being cost effective indicates sufficient positive outcomes for the money being spent. However, cost abstract The Problem: Community health centers (CHCs) are part of the United States' medical care safety net. Cost effective ness is a critical element of value in today's health policy environment. Not all costeffectiveness studies employ formal peerreviewed methodologies. A review of the literature on CHCs' cost effectiveness is necessary to assess whether a higher level of evidence is needed to guide future policy.
Purpose:
We sought to review the quality of the evidence on the economic value of CHCs and indicate whether a higher of level evidence would be useful for making policy.
Key Points: Evidence exists to support the general value of care in CHCs, but no evidence comes from formal eco nomic evaluations of CHC care.
Conclusion:
More formal costeffectiveness evaluations would enhance the economic argument for CHCs but will remain difficult to conduct and may be unnecessary in light of other work on the value of care in CHCs.
Keywords health facilities, health services research, uncompensated care, delivery of health services, health care quality access and evaluation effectiveness also refers to a set of formal methods that can be used to facilitate a structured, systematic comparison of treatments, interventions, and care systems.
Formal costeffectiveness analyses use standard, state oftheart methods that facilitate comparisons not only among public health interventions within a study but also across studies. Although the U.S. government has never established standards for costeffectiveness methods to guide policy, standards have been established by managed care pharmacy, 2 and an expert panel made recommenda tions based on the state of the art in 1996. 3 The panel's recommendations can be used to judge the quality of data, assumptions, and methods used in costeffec tiveness studies related to CHCs. A review of the literature on CHCs' cost effectiveness indicates whether more formal evidence is necessary to enhance the rationality of policy making process regarding the resource needs of CHCs.
concePtual Model Figure 1 shows several effects of programs at CHCs.
Each could be considered a component of the value prop osition for interventions at CHCs. In business, value proposition has been defined as "the complete customer experience, including products, services, and any interaction with the company." 4 In health policy and intervention implementation, value proposition could be reinterpreted as meaning "the complete effects of a policy or intervention."
The value proposition, considered from whatever perspec tive an interest group or decision maker might take, can be incorporated into the process of allocating resources to CHCs.
The effects of CHCs in the value proposition include, but are not limited to, economic components. The most basic noneconomic component of value is CHCs' ability to enhance access. Access alone provides little indication of how CHCs affect the health of the community, and effects that are closer to community health and expenditures on health care play a larger role in the policy making process. Therefore, it is important to note that access to care can facilitate utilization of care, and utilization can affect individuals' personal health and healthrelated quality of life. Improvements in individuals' health contribute to the public's health. Improvements in personal and public health facilitate community development. All other components of the value proposition can affect expenditures. Analysts can assess components of the value proposition from a variety of perspectives indicating whose costs and benefits matter.
Perspectives include societal (everyone's costs and benefits), the CHCs' alone, public payers' more generally, or the local community's.
All components of value are relevant to a general value proposition and thinking of something as "cost effective."
All should be considered in decisions about policy and implementation. However, trying to review the literature on all components of value would be a nearly impossible task.
Formal costeffectiveness analyses focus almost exclusively Figure 1 . components of the value proposition for community health center interventions being considered or implemented. These analyses provide a structured way to address two components of value. These components are connected to "value from a clearly delineated perspective" by solid lines in Figure 1 and are the focus of the review.
HEALTH CARE EXPENDITURES
A study's ability to add to the body of knowledge about the costeffectiveness of CHCs is determined in part by the degree to which it conforms to methodological standards.
Although formal criteria for judging such studies have been developed, the criteria were not designed for CHCs. Answers to several questions would facilitate formal costeffective ness analyses of, policy making for, and implementation of programs in CHCs. 
Methods
The published literature describing the components of the value proposition most directly related to the formal costeffectiveness analyses of CHCs was reviewed by search ing PubMed using the terms "cost effectiveness OR cost benefit" and "community health center OR federally quali fied health center OR CHC OR FQHC." Given the rapid rate of change in health care costs, articles published more than 5 years ago are unlikely to provide useful information about the formally assessed cost effectiveness of care provided at CHCs at present. Of these, only articles written in English focusing on health centers in the United States and performing empirical analyses were examined further.
Reviews were examined to obtain published references that may have been missed in the PubMed search.
For each study, the review notes whether the study actually was a formal costeffectiveness analysis. Several of the 179 articles were reviews. These were examined to identify articles that focused at least partially on the conceptual model of the value proposition for CHCs shown in Figure 1 . The published work by Proser as well as a National Association of Community Health Centers white paper served as the basis for identifying articles in the past five years that dealt with economic outcomes (primarily the cost of care) in CHC settings. 5, 6 The reviews support a favorable value proposition for CHCs; the components of proposition have not been evaluated in a formal cost effectiveness analysis. Table 1 provides a summary of the articles included in the review, listing the author and year, the component of the value proposition that is discussed, and a summary of the data and modeling that would need to be added to use the results in a formal costeffectiveness analysis.
Hadley and Cunningham reported that uninsured patients' proximity to federally qualified health centers (FQHC) was associated with lower levels of unmet need and decreased utilization of emergency care. 7 This result holds whether the patient actually used the FQHC. This is not a formal costeffectiveness analysis, but provides information on the access and utilization components of the value proposition and information relevant to public health. To be used as an input into a formal costeffectiveness analysis, the results need to be translated into health and expenditure values of decreased unmet need and use of emergency care.
Placing dollar values on the care provided at the CHC and which analysts had to model the incidence of hepatitis B, hepatitis C, and HIV. 18 Modeling the effects of CHCs or the care provided at them would be even more complex because of the need for a diverse set of disease models. Further, users of CHCs face many other environmental factors that can affect their lives so that standard epidemiological models may not be valid for this population. Longterm epidemiological models specific to this population may need to be developed.
Further, cost data can be difficult to summarize at any level more specific than that reported in standard administrative databases. Because CHCs obtain funds from multiple sources, trying to track their costs using the funds received from a single source would be meaningless. Determining which perspective to use is also difficult as the CHC population may be its users or may be the entire local population.
To facilitate formal costeffectiveness analyses that can add structure to policy debates, future analyses of care at
CHCs should extend beyond process measures. A formal costeffectiveness analyses could provide transparent infor mation about the economic value of care at CHCs. If such analyses prove to be impossible to conduct, the degree to which all components of the value proposition are under stood can be described for all concerned. Even this will facilitate rational decision making. Although having an understanding of all components of the value proposition is not equivalent to adding formal costeffectiveness analysis to the policy and implementation process, any additional structure is useful.
In conclusion, more formal costeffectiveness studies could enhance the discussion of policy options for improved access to primary care in underserved areas. Policy makers have several options to achieve this goal: (1) establishing and supporting a CHC; (2) subsidizing private providers through bonus payments, debt relief, or exchanging service for educational funding; or (3) expanding health insurance coverage. Costeffectiveness analyses, although continuing to be difficult to perform and needing to be supplemented by noneconomic considerations, will help in understanding whether the first option is most valuable.
